Board Members
Rupert Vessey
President, Research & Early Development, Celgene Corporation
Provides biotechnology reagents, instruments, and clinical diagnostic controls. Revenues are $703 million.
Updated about 5 years ago
Basic Info
| Types | Organization, Business |